Don't Get too Comfortable
Paxten's dad would rather not watch his son wither away:
“The fact is, my kid has leukemia, and if he doesn’t get this treatment, he will die,” Robert Mitchell said. “The way they made me feel was that they were pressuring us to take him home and let him die. We’ll try anything that has a chance of succeeding, and I will not give up fighting for it to be covered.CLiCK here
“Go to their Web site, and their mission statement says they treat each person with compassion,” he said. “I think that’s a bunch of hoopla.”
Paul Tate, a spokesman for Primary Physician Care, said the company is not authorized to discuss Paxten’s case.
to read more about Paxten in the Asheville Citizen Times
Get to know Paxten Andrew Mitchell
Ask Primary Physician Care
to let Paxten live!
Big Pharma is hedging its bets with the Democrats
Democrats have long served as the traditional enemy of Big Pharma, but in this presidential campaign, the left is taking the lion's share of drugmaker money.CLiCK here to read more...
Democratic senators Barack Obama and Hillary Clinton are the top recipients of donations from the pharmaceutical industry, according to The Center for Responsive Politics, a non-profit, non-partisan research group in Washington, D.C. Meanwhile, donations to Sen. John McCain, who was recently endorsed by President Bush as the official Republican candidate, pale in comparison.
Track health industry contributions to the candidates at 'SiCKO's for Sale'
"Cheating Medicaid out of millions..."
Merck recently agreed to pay $650 million to settle charges that it overbilled the government for drugs such as Vioxx and Zocor.
Prosecutors say the drugmaker gave pills to hospitals at virtually no cost to hook poor patients on expensive medicine. When the patients left the hospital, they often continued taking the drugs, but with the government footing the higher bill. CLiCK here to read more...
The Merck settlement culminates an investigation that began in 2000 and is one of the first in a series of cases centering on whether drugmakers used unfair pricing practices to bilk the government. The Justice Department is looking into 630 health-care whistleblower claims.